Eloxx Pharmaceuticals is a clinical-stage company developing exaluren — an investigational therapy for people with Alport syndrome and ADPKD caused by nonsense mutations
Eloxx Pharmaceuticals is a clinical-stage company developing exaluren — an investigational therapy for people with Alport syndrome and ADPKD caused by nonsense mutations.